AVITA Medical RCEL
NASDAQ RCEL
$10.07 -0.27 (-2.61%)
As of: Aug 20, 2026 · 3:59 PM EDT

AVITA Medical (RCEL) Return on Capital Employed Growth (3y) (2023 - 2026)

AVITA Medical (RCEL) Return on Capital Employed Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (3y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -236.00
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 281.00
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 145.00
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 446.00
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -433.00
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 1,627.00
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -62.00
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 370.00
10 AVITA Medical 312.73 Mn 301.59 Mn 17.77 Mn 27,442.00

Historic Data

Download Data
DateValue
Jun 30, 2026 27,442.00
Dec 31, 2025 167,263.00
Sep 30, 2025 471,832.00
Mar 31, 2025 -5,823.00
Sep 30, 2024 -5,403.00
Jun 30, 2024 -3,166.00
Mar 31, 2024 -985.00
Dec 31, 2023 1,734.00
Sep 30, 2023 1,306.00